MESA AIR GROUP INC (MESA)

US5904791358 - Common Stock

1.13  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MESA. MESA was compared to 23 industry peers in the Passenger Airlines industry. Both the profitability and financial health of MESA have multiple concerns. MESA is not valued too expensively and it also shows a decent growth rate.



1

1. Profitability

1.1 Basic Checks

MESA had negative earnings in the past year.
MESA had a positive operating cash flow in the past year.
In multiple years MESA reported negative net income over the last 5 years.
MESA had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

MESA's Return On Assets of -14.22% is on the low side compared to the rest of the industry. MESA is outperformed by 65.22% of its industry peers.
MESA's Return On Equity of -70.02% is on the low side compared to the rest of the industry. MESA is outperformed by 65.22% of its industry peers.
Industry RankSector Rank
ROA -14.22%
ROE -70.02%
ROIC N/A
ROA(3y)-9.54%
ROA(5y)-4.7%
ROE(3y)-38.64%
ROE(5y)-19.75%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of MESA (16.97%) is worse than 73.91% of its industry peers.
In the last couple of years the Gross Margin of MESA has declined.
The Profit Margin and Operating Margin are not available for MESA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.23%
GM growth 5Y-12.93%

0

2. Health

2.1 Basic Checks

MESA does not have a ROIC to compare to the WACC, probably because it is not profitable.
MESA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MESA has more shares outstanding
The debt/assets ratio for MESA is higher compared to a year ago.

2.2 Solvency

MESA has an Altman-Z score of 0.22. This is a bad value and indicates that MESA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.22, MESA is doing worse than 69.57% of the companies in the same industry.
A Debt/Equity ratio of 2.13 is on the high side and indicates that MESA has dependencies on debt financing.
MESA has a Debt to Equity ratio (2.13) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF N/A
Altman-Z 0.22
ROIC/WACCN/A
WACC6.2%

2.3 Liquidity

A Current Ratio of 0.45 indicates that MESA may have some problems paying its short term obligations.
With a Current ratio value of 0.45, MESA is not doing good in the industry: 73.91% of the companies in the same industry are doing better.
MESA has a Quick Ratio of 0.45. This is a bad value and indicates that MESA is not financially healthy enough and could expect problems in meeting its short term obligations.
MESA has a Quick ratio of 0.29. This is amonst the worse of the industry: MESA underperforms 82.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.29

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.94% over the past year.
Looking at the last year, MESA shows a decrease in Revenue. The Revenue has decreased by -6.63% in the last year.
Measured over the past years, MESA shows a decrease in Revenue. The Revenue has been decreasing by -6.08% on average per year.
EPS 1Y (TTM)57.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.72%
Revenue 1Y (TTM)-6.63%
Revenue growth 3Y-2.96%
Revenue growth 5Y-6.08%
Sales Q2Q%-3.4%

3.2 Future

Based on estimates for the next years, MESA will show a very strong growth in Earnings Per Share. The EPS will grow by 55.47% on average per year.
The Revenue is expected to grow by 14.62% on average over the next years. This is quite good.
EPS Next Y91.1%
EPS Next 2Y55.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.08%
Revenue Next 2Y14.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

5

4. Valuation

4.1 Price/Earnings Ratio

MESA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 1.63, the valuation of MESA can be described as very cheap.
Based on the Price/Forward Earnings ratio, MESA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of MESA to the average of the S&P500 Index (22.83), we can say MESA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.63

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MESA.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.92

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MESA's earnings are expected to grow with 55.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MESA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MESA AIR GROUP INC

NASDAQ:MESA (12/20/2024, 8:24:04 PM)

1.13

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)12-12 2024-12-12/amc
Earnings (Next)N/A N/A
Inst Owners11.84%
Inst Owner Change-4.21%
Ins Owners5.28%
Ins Owner Change0%
Market Cap46.68M
Analysts43.33
Price Target2.04 (80.53%)
Short Float %0.74%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.28%
Min Revenue beat(2)-26.11%
Max Revenue beat(2)-4.44%
Revenue beat(4)0
Avg Revenue beat(4)-9.94%
Min Revenue beat(4)-26.11%
Max Revenue beat(4)-1.65%
Revenue beat(8)1
Avg Revenue beat(8)-7.12%
Revenue beat(12)3
Avg Revenue beat(12)-5.49%
Revenue beat(16)5
Avg Revenue beat(16)-4.12%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.63
P/S 0.1
P/FCF N/A
P/OCF 5.02
P/B 0.35
P/tB 0.35
EV/EBITDA 11.92
EPS(TTM)-2.31
EYN/A
EPS(NY)0.69
Fwd EY61.38%
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)0.23
OCFY19.93%
SpS11.51
BVpS3.27
TBVpS3.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.22%
ROE -70.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.97%
FCFM N/A
ROA(3y)-9.54%
ROA(5y)-4.7%
ROE(3y)-38.64%
ROE(5y)-19.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.23%
GM growth 5Y-12.93%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF N/A
Debt/EBITDA 9.02
Cap/Depr 47.61%
Cap/Sales 4.62%
Interest Coverage N/A
Cash Conversion 29.18%
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.29
Altman-Z 0.22
F-Score5
WACC6.2%
ROIC/WACCN/A
Cap/Depr(3y)43.81%
Cap/Depr(5y)64.93%
Cap/Sales(3y)6.15%
Cap/Sales(5y)8.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.72%
EPS Next Y91.1%
EPS Next 2Y55.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.63%
Revenue growth 3Y-2.96%
Revenue growth 5Y-6.08%
Sales Q2Q%-3.4%
Revenue Next Year13.08%
Revenue Next 2Y14.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year518.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.18%
OCF growth 3YN/A
OCF growth 5YN/A